嘉和美康 (688246.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

18.8x

EV/EBITDA

−9.9x

Market Cap

CNY 2.35B

MomentumView details →

1D Return

−2.01%

YTD Return

—

RSI (14)

43.6

ValuationView details →

P/E (Fwd)

18.8x

EV/EBITDA

−9.9x

Market Cap

CNY 2.35B

RSI (14)

43.6

MomentumView details →

1D Return

−2.01%

YTD Return

—

ProfitabilityView details →

Gross Margin

12.85%

Net Margin

−63.80%

EBITDA Margin

−64.90%

ROE (TTM)

−19.18%

ROA (TTM)

−12.05%

Asset Turnover

0.18x

GrowthView details →

Revenue YoY

−32.05%

EPS YoY

—

FCF YoY

+28.99%

Revenue CAGR 3Y

−17.40%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−CNY 0.48

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.23%

Capital & dividendView details →

Debt/Equity

0.19x

Current Ratio

1.98x

Quick Ratio

1.24x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

387.70M

Net Income (TTM)

−247.37M

Op. CF (TTM)

−54.40M

Next earningsOct 26, 2026 →

Latest newsMore news →

Jiahe Meikang announced its 2026 first-half results, reporting a net loss attributable to shareholders of 80.0134 million yuan, compared with a loss of 116 million yuan in the same period of 2025.8d ago

Similar companies

Prestige Consumer Healthcare Inc.PBH Guardian Pharmacy Services, Inc.GRDN Guanze Medical Information Industry (Holding) Co., Ltd.02427.HK Lung Fung Group Holdings Limited02290.HK 160 Health International Ltd.02656.HK Medlive Technology Co., Ltd.02192.HK Find similar companies →

Latest newsMore news →

Jiahe Meikang announced its 2026 first-half results, reporting a net loss attributable to shareholders of 80.0134 million yuan, compared with a loss of 116 million yuan in the same period of 2025.8d ago